1. Home
  2. CHCT vs HUMA Comparison

CHCT vs HUMA Comparison

Compare CHCT & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHCT
  • HUMA
  • Stock Information
  • Founded
  • CHCT 2014
  • HUMA 2004
  • Country
  • CHCT United States
  • HUMA United States
  • Employees
  • CHCT N/A
  • HUMA N/A
  • Industry
  • CHCT Real Estate Investment Trusts
  • HUMA Biotechnology: Pharmaceutical Preparations
  • Sector
  • CHCT Real Estate
  • HUMA Health Care
  • Exchange
  • CHCT Nasdaq
  • HUMA Nasdaq
  • Market Cap
  • CHCT 422.2M
  • HUMA 427.2M
  • IPO Year
  • CHCT 2015
  • HUMA N/A
  • Fundamental
  • Price
  • CHCT $16.00
  • HUMA $1.68
  • Analyst Decision
  • CHCT Buy
  • HUMA Strong Buy
  • Analyst Count
  • CHCT 4
  • HUMA 6
  • Target Price
  • CHCT $21.25
  • HUMA $14.60
  • AVG Volume (30 Days)
  • CHCT 263.4K
  • HUMA 6.6M
  • Earning Date
  • CHCT 04-29-2025
  • HUMA 05-09-2025
  • Dividend Yield
  • CHCT 11.75%
  • HUMA N/A
  • EPS Growth
  • CHCT N/A
  • HUMA N/A
  • EPS
  • CHCT N/A
  • HUMA N/A
  • Revenue
  • CHCT $115,786,000.00
  • HUMA N/A
  • Revenue This Year
  • CHCT $8.02
  • HUMA N/A
  • Revenue Next Year
  • CHCT $8.13
  • HUMA $1,178.15
  • P/E Ratio
  • CHCT N/A
  • HUMA N/A
  • Revenue Growth
  • CHCT 2.61
  • HUMA N/A
  • 52 Week Low
  • CHCT $14.76
  • HUMA $1.15
  • 52 Week High
  • CHCT $27.62
  • HUMA $9.97
  • Technical
  • Relative Strength Index (RSI)
  • CHCT 36.79
  • HUMA 38.93
  • Support Level
  • CHCT $14.76
  • HUMA $1.43
  • Resistance Level
  • CHCT $18.42
  • HUMA $1.62
  • Average True Range (ATR)
  • CHCT 0.69
  • HUMA 0.18
  • MACD
  • CHCT -0.10
  • HUMA 0.07
  • Stochastic Oscillator
  • CHCT 34.02
  • HUMA 70.67

About CHCT Community Healthcare Trust Incorporated

Community Healthcare Trust Inc is an integrated healthcare real estate company in the United States. The company owns and acquires, or finances, real estate properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers in non-urban markets. The company derives majority of its revenues from its real estate property and mortgage notes portfolio. The company's rental and mortgage interest income is recognized based on contractual arrangements with its tenants and borrowers.

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.

Share on Social Networks: